This move is archived. Current quotes and coverage live on the stock page.
Follow ICLR
ICON PLC experienced a notable increase in its stock price, reflecting positive investor sentiment.
ICON PLC (NASDAQ:ICLR) went up yesterday by 6.10%, closing at CA$173.90. This surge comes amid a backdrop of mixed sentiment in the healthcare sector, with investors showing renewed interest in the clinical research organization.
Investor takeaway: The recent surge in ICON PLC's stock price may indicate a temporary rebound, but investors should remain cautious given the company's underlying challenges and competitive dynamics.
ICON PLC
ICLR.US
ICLR.US
ICON PLC
WealthAwesomeMarket cap
$15.83B
P/E
84.5x
52W high
$219.04
52W low
$66.57
1W change
+14.08%
Beta
1.24
Analyst Price Targets
Based on 18 analysts covering ICLR · as of Nov 2, 2026
Wall Street analysts forecast ICLR stock price to rise 8.4% over the next 12 months.
Consensus
Buy4.00 / 5.00
Avg. Target
C$229.06
+8.4% Upside
Previously C$219.35 on Oct 30, 2026
Current Price
C$211.36
Last close
Analyst Breakdown (18 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ICLR's historical volatility
30-Day Vol
61.4%
Annualized
90-Day Vol
47.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$252.68
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$224.32 | C$181.50 – C$277.26 |
| 60 trading days | C$238.08 | C$176.44 – C$321.25 |
| 90 trading days | C$252.68 | C$175.07 – C$364.70 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Bull case
The rise in stock price could suggest that investors are feeling more confident about ICON's future. This optimism may be fueled by expectations of growth in the biopharma sector and the company’s potential to capitalize on new opportunities.
Bear case
Despite the recent gains, ICON PLC is still facing significant challenges. The company has a shrinking competitive edge and is under pressure regarding its pricing power. Recent insights from Marram Investment Management highlight concerns about its competitive position, indicating that the current price surge might not last.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
